BGT-002
BGT-002 (326E) is an orally active dual ACLY inhibitor and PPARα agonist. It reduces lipogenesis by inhibiting synthesis and promoting excretion. BGT-002 has demonstrated efficacy in vivo for improving metabolic dysfunction-associated steatohepatitis (MASH) and alleviating hyperlipidemia. It is applicable for research on hypercholesterolemia and MASH.
Product Specifications
CAS Number
2127387-94-2
Smiles
C (CCCCC/C=C/CCCCC (C (O) =O) (C) C) (C (O) =O) (C) C
Molecular Formula
C19H34O4
Molecular Weight
326.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC215402L3V 200 µL
FUBP3 (NM_003934) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
TL312444V 500 µL Each
H2AC6 Human shRNA Lentiviral Particle (Locus ID 8334)
Sign In for Pricing
View Details